Brown Brothers Harriman & Co’s Cogentix Medical, Inc. CGNT Stock Holding History

Brown Brothers Harriman & Co’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-14,000	Closed	-$54K	–	905
2018 Q1	$54K	Hold	14,000	–	–	﹤0.01%	470
2017 Q4	$44K	Hold	14,000	–	–	﹤0.01%	534
2017 Q3	$36K	Hold	14,000	–	–	﹤0.01%	512
2017 Q2	$24K	Hold	14,000	–	–	﹤0.01%	575
2017 Q1	$25K	Hold	14,000	–	–	﹤0.01%	570
2016 Q4	$28K	Hold	14,000	–	–	﹤0.01%	579
2016 Q3	$25K	Hold	14,000	–	–	﹤0.01%	520
2016 Q2	$13K	Hold	14,000	–	–	﹤0.01%	604
2016 Q1	$15K	Hold	14,000	–	–	﹤0.01%	540
2015 Q4	$18K	Hold	14,000	–	–	﹤0.01%	575
2015 Q3	$17K	Hold	14,000	–	–	﹤0.01%	635
2015 Q2	$23K	Buy	+14,000	New	+$22.9K	﹤0.01%	596

Brown Brothers Harriman & Co's CGNT Position: Q2 2018 in Review

Brown Brothers Harriman & Co sold out of Cogentix Medical, Inc. (CGNT) in Q2 2018, closing a stake of 14,000 shares — an estimated $54K sold.

Brown Brothers Harriman & Co first reported a position in CGNT in Q2 2015 and held it in 12 quarters. The position peaked at $54K in Q1 2018. 0 funds tracked by Wall St. Rank hold CGNT as of Q2 2018.

Brown Brothers Harriman & Co reported no remaining Cogentix Medical, Inc. position as of Q2 2018 after selling out during the quarter.
Brown Brothers Harriman & Co sold 14,000 Cogentix Medical, Inc. shares in Q2 2018, an estimated $54K.
Brown Brothers Harriman & Co first reported a position in Cogentix Medical, Inc. in Q2 2015 and held it in 12 quarters.
Brown Brothers Harriman & Co's Cogentix Medical, Inc. position peaked at $54K in Q1 2018.
0 funds tracked by Wall St. Rank held Cogentix Medical, Inc. as of Q2 2018.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2018, filed 14 Aug 2018.